S

Shanghai MicroPort EP Medtech Co Ltd
SSE:688351

Watchlist Manager
Shanghai MicroPort EP Medtech Co Ltd
SSE:688351
Watchlist
Price: 20.07 CNY -6.3% Market Closed
Market Cap: 9.4B CNY
Have any thoughts about
Shanghai MicroPort EP Medtech Co Ltd?
Write Note

Shanghai MicroPort EP Medtech Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai MicroPort EP Medtech Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai MicroPort EP Medtech Co Ltd
SSE:688351
Cost of Revenue
-ÂĄ120.7m
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cost of Revenue
-ÂĄ486.1m
CAGR 3-Years
-51%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cost of Revenue
-ÂĄ3.7B
CAGR 3-Years
1%
CAGR 5-Years
-6%
CAGR 10-Years
-14%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cost of Revenue
-ÂĄ12.8B
CAGR 3-Years
-15%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Cost of Revenue
-ÂĄ518.3m
CAGR 3-Years
-12%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cost of Revenue
-ÂĄ5.9B
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shanghai MicroPort EP Medtech Co Ltd
Glance View

Market Cap
9.4B CNY
Industry
Health Care

Shanghai MicroPort EP MedTech Co., Ltd. engages in the research and development, production, and sale of medical devices. The company is headquartered in Shanghai, Shanghai and currently employs 485 full-time employees. The company went IPO on 2022-08-31. The firm is focused on the fields of electrophysiology intervention treatment and ablation treatment, and it is committed to providing integrated diagnosis and ablation treatment solution with precision intervention navigation at its core. The Company’s main products are heart electrophysiology equipment and related supplies. The firm distributes products both in the domestic market and to overseas markets, including France, Italy, and Spain, among others.

Intrinsic Value
6.42 CNY
Overvaluation 68%
Intrinsic Value
Price
S

See Also

What is Shanghai MicroPort EP Medtech Co Ltd's Cost of Revenue?
Cost of Revenue
-120.7m CNY

Based on the financial report for Dec 31, 2023, Shanghai MicroPort EP Medtech Co Ltd's Cost of Revenue amounts to -120.7m CNY.

What is Shanghai MicroPort EP Medtech Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-45%

Over the last year, the Cost of Revenue growth was -49%. The average annual Cost of Revenue growth rates for Shanghai MicroPort EP Medtech Co Ltd have been -45% over the past three years .

Back to Top